Author: Alexis Peyroles

Alexis Peyroles is CEO of OSE Immunotherapeutics, a clinical-stage biotechnology company based in Nantes, France.

Creating Consistent Value in Biotech Without Diluting Stakeholders

One of the greatest challenges for pre-commercial biotech companies is consistently generating capital necessary for operating costs and for R&D of new products that provide value to stakeholders, both for investors and patients. At OSE Immunotherapeutics we implemented a business model that allows us to be one of the rare French biotech companies without commercial … Continue reading “Creating Consistent Value in Biotech Without Diluting Stakeholders”